1LiF,Chong ZZ,Maiese K.Erythropoietin on a tightrope:balan-cing neuronal and vascular p rotection between intrinsic and extrin-sic pathways[J].Neurosignals,2004,13(6):265-289.
2Maiese K,LiF,Chong ZZ.New avenues of exp loration for eryth-ropoietin[J].JAMA,2005,293(1):90-95.
5Mitsuma WI,to M,kodama M,et al.Cardioprotective effect.of re-combinant human erythropoietin in rats with experimental autoim-mune myocarditis[J].Biochem Biophys Bes Commun,2006,334(3):987-994.
6Liu X,Xie W,Liu P,et al.Mechanism of the cardioprotection of rh-EPO pretreatment on suppressing the inflammatory response inischemia-repedusion[J].Life Sci,2006,7s(19):2255-2264.
9Prunier F,Pfister O,Hadri L,et al.Delayed erythropoietin therapyreduces post-MI cardiac remodeling only at a dose that mobilizesendothelial progenitor cells[J].J Pharmacol Sci,2006,101(1):H522-H529.
10Parsa CJ,Kim J,Riel RU,et al.Cardioprotective effectsof erythro-poietin in the reperfused ischemic heart:a potential role for cardi-ac fibroblasts[J].J Biol Chem,2004,279:20655-20662.
8Tramontano AF, Muniyappa R, Black AD, et al. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway[ J]. Biochemical and Biophysical Research Communications, 2003,308 (4) :990 - 994.
9Cai Z, Manalo D J, Wei G, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury[ J ]. Circulation,2003,108 ( 1 ) :79 - 85.
10Bullard A J, Govewalla P, Yellon DM. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo[ J]. Basic Res Cardiol,2005,100(5) :397 -403.
